Regular Article
Inflammation and Interleukin-6 Mediate Reductions in the Hepatic Expression and Transcription of the mdr1a and mdr1b Genes

https://doi.org/10.1006/mcbr.2001.0288Get rights and content

Abstract

In order to elucidate the mechanisms involved in the downregulation of mdr 1 gene expression reported in experimentally-induced inflammation, we examined the effects of experimentally-induced inflammation and interleukin-(IL-) 6 on transcriptional control of the mdr1 genes in rats. RNA, nuclear extracts, and nuclear protein fractions were isolated from livers harvested from saline or turpentine-treated male Sprague–Dawley rats or from IL-6 treated or nontreated (controls) cultured rat hepatocytes. mdr gene expression and regulation was examined by RT-PCR, mRNA stability studies, nuclear run-on analysis of transcription, and gel shift analysis of promoter-transcription factor interaction. As compared to controls, significantly lower levels of mdr1a and mdr1b mRNA and significantly decreased mdr1a and mdr1b transcription rates were observed in livers isolated from the turpentine-treated rats. In vitro treatments of cultured hepatocytes with IL-6 also suppressed mdr1a and mdr1b mRNA expression and imposed similar reductions in mdr1a and mdr1b transcriptional activity. Significant effects of IL-6 on mdr1 mRNA stability were not seen. Our results indicate that reductions in mdr1 expression in experimental models of inflammation likely occurs through altered gene transcription. Furthermore, as IL-6 was found to decrease mdr1 expression and gene transcription rates in vitro, this cytokine is likely involved in the reduction of mdr1 expression that is seen in vivo during an acute inflammatory response.

References (37)

  • J. Silverman et al.

    Cloning and characterization of a member of the rat multidrug resistance gene family

    Gene

    (1991)
  • T. Kishimoto et al.

    Cytokine signal transduction

    Cell

    (1994)
  • W. Tang et al.

    Endotoxin downregulates hepatic expression of P-glycoprotein and MRP2 in 2-acetylaminofluorene-treated rats

    Mol. Cell Biol. Res. Commun.

    (2000)
  • L. Yu et al.

    Three distinct nuclear protein binding sites in the promoter of the murine multidrug resistance mdr1b gene

    J. Biol. Chem.

    (1993)
  • N.J. Combates et al.

    NF-IL6, a member of the C/EBP family of transcription factors, binds and trans-activates the human MDR1 gene promoter

    J. Biol. Chem.

    (1994)
  • L. Denson et al.

    IL-1beta suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation

    J. Biol. Chem.

    (2000)
  • D.-W. Shen et al.

    Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification

    Science

    (1986)
  • P. Borst et al.

    Mice with disrupted P-glycoprotein genes

  • Cited by (61)

    • Disease-drug and drug-drug interaction in COVID-19: Risk and assessment

      2021, Biomedicine and Pharmacotherapy
      Citation Excerpt :

      P-glycoprotein (Pgp) is one of the most comprehensively explored ABC transporter that has been studied against the response of inflammations. Several studies suggested the association of IL-6 as direct administration of this cytokine diminished the Pgp mRNA level and protein expression in hepatic cell lines as well as in vivo in mice [21,22]. In humans, intestinal epithelium showed a decrease in Pgp expression in inflammatory conditions [23].

    • Regulation of Drug Transporters by Inflammation

      2017, Drug Metabolism in Diseases
    View all citing articles on Scopus

    Abbreviations used: PGP, P-glycoprotein; mdr1, rat and murine multidrug resistance genes mdr1a and mdr1b; MDR1, human multidrug resistance gene; IL-1β, interleukin-1β; IL-6, interleukin-6; Rh123, rhodamine 123; RT-PCR, reverse transcription-polymerase chain reaction; GADPH, glyceraldehyde 3-phosphate dehydrogenase; DEX, dexamethasone.

    1

    To whom correspondence should be addressed. Fax: 416-978-8511. E-mail: [email protected].

    View full text